Nps Makes Progress On Drug Commercializations

NJBIZSeptember 30, 2009

Linked as:

Summary


NPS's revenue dropped to $16.3 million in this year's first quarter from $25.2 million in the same quarter a year ago, when it had logged nonrecurring sales of inventory of a hormone injection drug to Nycomed, of France.

See the full content of this document

Extract


Nps Makes Progress On Drug Commercializations

NPS Pharmaceuticals, of Bedminster, last ...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company